FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 72541

News■ Unclear/unknown

Iambic prices its IPO, seeking to raise up to $160m - pharmaphorum

KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-09 06:58 UTC
LAST UPDATE2026-10-09 06:58 UTC
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

Small biotech IPO pricing tests investor appetite for early-stage pharma amid rate uncertainty.

Small biotech IPO tests market openness
CATALYST TO WATCH

Pricing outcome and first-day trading

MAIN RISK

Weak demand signals IPO window shut

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED
№ 01googlenewsnews.google.com · PRIMARY2026-10-09 06:58 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.